Omnicell (OMCL) Total Debt Growth (1y) (2017 - 2019)
Powered by 
Analysis
Omnicell (OMCL) Total Debt Growth (1y) (2017 - 2019) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Debt Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 187.42 Bn | 182.47 Bn | 7.27 Bn | 142.67% |
| 2 | Intuitive Surgical | 129.78 Bn | 124.69 Bn | 1.96 Bn | - |
| 3 | Medtronic | 120.53 Bn | 112.33 Bn | 6.34 Bn | -1.59% |
| 4 | Stryker | 116.28 Bn | 112.80 Bn | 4.50 Bn | -9.88% |
| 5 | Boston Scientific | 69.29 Bn | 68.99 Bn | 3.85 Bn | 8.95% |
| 6 | Edwards Lifesciences | 51.83 Bn | 47.68 Bn | 1.35 Bn | 0.12% |
| 7 | Alcon | 34.36 Bn | 32.91 Bn | 1.68 Bn | -9.07% |
| 8 | Dexcom | 33.17 Bn | 31.23 Bn | 830.00 Mn | - |
| 9 | Resmed | 32.94 Bn | 31.47 Bn | 861.22 Mn | 35.55% |
| 10 | Omnicell | 1.57 Bn | 1.28 Bn | 152.94 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2019 | -64.29% |
| Sep 30, 2019 | -58.27% |
| Jun 30, 2019 | -61.48% |
| Mar 31, 2019 | -53.41% |
| Dec 31, 2018 | -33.37% |
| Sep 30, 2018 | -3.89% |
| Jun 30, 2018 | 2.23% |
| Mar 31, 2018 | -2.96% |
| Dec 31, 2017 | -17.32% |
| Sep 30, 2017 | -13.85% |
| Jun 30, 2017 | -13.72% |
| Mar 31, 2017 | -5.68% |